LPCN Nilai Total Aset Perusahaan Lipocine Inc

The market dynamics of Lipocine Inc. (LPCN) on the GURU.Markets platform show total assets at 21.20. Lipocine Inc. (LPCN) relies on the capacities of CDMO partners for drug production while maintaining its R&D centers in Utah. Top-tier biochemists are drawn by the prospects of an innovative drug delivery method, yet heavy investments in steatohepatitis therapy and uncertainty regarding clinical trial outcomes are exerting significant financial pressure on the business.

LPCN (Lipocine Inc.) riwayat Total Aset Perusahaan saka 04.07.2022 nganti 30.10.2026

Rincian analitis lan laporan data perusahaan Lipocine Corp (LPCN)

- kuotasi lan prakiraan analis:

Kurs saham lipocine.com|LPCN - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Lipocine Corporation|LPCN - Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi Saham Lipocine|LPCN - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku lipocine.com|LPCN - Aset Agregat Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Lipocine Inc.|LPCN - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Lipocine Corporation|LPCN - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Lipocine Corporation|LPCN - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Lipocine|Indikator likuiditas cepet lipocine.com

- indikator pendapatan resik lan kelipatan nilai:

LPCN - Bathi resik

Pambiji fundamental:Lipocine Inc.

Total assets represent the aggregate value of a company's resources, calculated reversely via ROA as the sum of liabilities and equity. The total assets trend on GURU.Markets reflects the financial strength of Lipocine Inc. (LPCN), where the value of intellectual property and patents for drug delivery systems plays a key role, shielding the company from direct price competition in the endocrine sector.

Pesaing wigati